IMMUNIC, INC. — Director's Dealing 2025

Jun 20, 2025

SEC Form 4/A — Form 4/A

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2025-06-05

Reporting Person: Whaley Glenn (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-06-05	Stock Option	$0.7729	A	503500	Acquired	2035-06-05	Common Stock (503500)	Direct

Footnotes

F1: 25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months.